• SENSEX 77,966.35
    -187.90 (--0.24%)
  • BANKNIFTY 57,885.85
    439.60 (+0.77%)
  • Tenneco Clean
    524.00 437.85(%)
  • Finolex Cables
    1,375.00 1,375.00(%)
  • Godrej Consumer
    908.00 908.00(%)
  • Max Healthcare
    1,002.00 903.50(%)
  • HDFC Bank
    722.00 722.00(%)
  • TD Power Systems
    1,529.00 1,529.00(%)
  • SBI
    1,085.00 1,234.80(%)
  • Grasim Inds
    3,270.00 2,504.35(%)
  • Hindustan Copper
    569.85 759.20(%)
  • Hindalco Inds.
    1,088.25 1,179.35(%)
  • TCS
    2,301.10 1,976.00(%)
  • Multi Comm. Exc.
    2,987.85 3,479.80(%)
  • Hind.Aeronautics
    5,054.40 5,054.40(%)
  • Fortis Health.
    879.30 767.30(%)
  • Apar Inds.
    18,432.40 18,432.40(%)
  • Axis Bank
    1,216.80 1,041.30(%)
  • Billionbrains
    197.95 227.00(%)
  • Marksans Pharma
    319.90 319.90(%)
  • Ardee Industries
    73.60 73.60(%)
  • LG Electronics
    1,584.00 1,736.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Bliss GVS Pharma Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 79.0
  • ISIN : INE416D01022
489.55 -5 (-0.91%)
  • As on 12 Aug 2026 (EOD)

  • Today’s Low

    477.05

  • Today’s High

    505.95

  • Open

    491.10

  • Perv Close

    494.05

  • 52W Low

    118.00

  • 52W High

    553.00

Key Indicators

  • P/E(TTM)

    52.89

  • Mar.Cap (₹Cr.)

    5,202.70

  • Div & Yield %

    0.20

  • Book Value(₹)

    108.70

  • Debt-Equity Ratio

    -0.91

  • AGM Date

    12-Aug-2026

  • EPS

    9.23

  • P/E Ratio

    52.89

Financials Ratios

  • Debt-Equity Ratio

    0.11

  • Mar.Cap (₹Cr.)

    5,202.70

  • RONW (%)

    11.02

  • ROCE (%)

    14.84

Score Board

  • Equity (₹ in Cr.)

    10.62

  • BV (₹)

    108.70

  • Sales( ₹ in Cr.)

    729.81

  • NP (in Cr.)

    98.13

  • NP Var(%)

    42.0

  • Div%

    100.0

  • CPS (₹)

    12.20

  • EPS (₹)

    9.20

  • Traded Value (₹ in Lakhs)

    5,263.86

  • 52 Week High

    553.00

  • 52 Week Low

    118.00

  • Price BSE

    495.0

  • Price NSE

    494.00

  • Market Capital( in Cr.)

    5,263.86

  • P/C Ratio

    40.70

  • P/E Ratio

    53.60

  • Price Vs.BV

    9.20

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 729.81 667.20 605.46 598.34 636.36 465.51
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 729.81 667.20 605.46 598.34 636.36 465.51
Other Income 43.72 36.22 33.50 50.77 35.37 17.68
Stock Adjustments 25.62 -6.63 6.36 -21.24 8.90 8.85
Total Income 799.15 696.79 645.32 627.87 680.63 492.04
EXPENDITURE :            
Raw Materials 368.25 339.47 305.83 293.66 352.84 262.15
Power and Fuel Cost 12.95 9.76 8.81 5.80 7.09 6.99
Employee Cost 121.50 99.42 82.59 72.54 65.06 58.61
Other Manufacturing Expenses 20.05 15.50 17.25 11.57 11.54 7.49
Selling and Administration Expenses 79.30 78.23 66.73 66.90 67.07 36.90
Miscellaneous Expenses 21.50 26.61 64.52 36.48 32.45 10.76
Employee Benefit Expenses 121.50 99.42 82.59 72.54 65.06 58.61
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 623.54 568.98 545.74 486.95 536.05 382.90
Operating Profit 175.59 127.80 99.59 140.93 144.57 109.14
Interest 11.11 6.58 5.81 10.06 4.32 4.19
Gross Profit 164.48 121.22 93.78 130.87 140.25 104.95
Depreciation 31.02 27.05 23.52 15.17 13.85 13.76
Profit Before Tax 133.46 94.17 70.26 115.70 126.40 91.19
Current Tax 42.54 29.99 26.34 34.42 31.92 21.52
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -5.95 -4.79 -6.72 -4.21 1.81 2.16
Reported Net Profit 96.87 68.97 50.64 85.48 92.66 67.50
Extraordinary Items -1.25 -0.14 -25.47 0.26 2.09 -0.02
Adjusted Net Profit 98.12 69.11 76.11 85.22 90.57 67.52
Adjustment below Net Profit -0.18 -0.56 -0.15 -0.67 0.30 0.52
P & L Balance brought forward 956.86 892.57 846.18 765.33 676.22 613.36
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 9.91 4.12 4.10 3.97 3.86 5.16
P & L Balance carried down 1,043.65 956.86 892.57 846.18 765.33 676.22
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 100.00 50.00 50.00 50.00 50.00 50.00
Dividend Per Share(Rs) 0.10 0.50 0.50 0.50 0.50 0.50
Earnings Per Share-Unit Curr 9.16 6.55 4.84 8.21 8.94 6.54
Earnings Per Share(Adj)-Unit Curr 9.16 6.55 4.84 8.21 8.94 6.54
Book Value 109.20 100.47 94.41 89.96 82.12 73.26
Book Value(Adj)-Unit Curr 109.20 100.47 94.41 89.96 82.12 73.26

Shareholding Pattern

  • Promoter Group

    35.01%

  • Public Share Holding

    64.99%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 37,130,124 35.01 37,130,124 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 37,130,124 35.01 37,130,124 5
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 8,562,026 8.07 8,562,026 44
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 3,440,388 3.24 3,440,388 1
Mutual Funds / UTI 272,014 0.26 272,014 3
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 6,327,739 5.97 6,327,739 13
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 18,602,167 17.54 18,602,167 61
2] Non Institution
Bodies Corporate 10,282,077 9.69 10,256,677 261
Clearing Members 238,541 0.22 238,541 32
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,190,067 1.12 1,119,467 821
Foreign Non Institution Other 200 0.00 200 1
Hindu Undivided Families 2,438,438 2.30 2,438,438 793
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 11,914,135 11.23 11,914,135 11
Individuals holding nominal share capital up to Rs. 1 lakh 19,659,079 18.54 18,570,977 44,725
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 11,600 0.01 11,600 1
Others 2,665,407 2.51 2,665,407 3
Sub Total 50,323,931 47.45 49,121,769 46,701
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 106,056,222 100.00 104,854,060 46,767

Company Background

Bliss GVS Pharma LtdPharmaceuticals - Indian - Formulations

  • Bliss GVS Pharma Ltd
  • BSE Code : 79.0
  • ISIN : INE416D01022

  • Incorporation Year

    1984

  • Registered Office

    102 Hyde Park Sakivihar Road
    Andheri East, Mumbai,
    Maharashtra-400072

  • Telephone

    91-22-42160000

  • FAX

    91-22-28563930

  • Chairman

    Nandkumar Kashinath Chodankar

  • Managing Director

  • Company Secretary

    Aditi Bhatt

  • Auditor

    Kalyaniwalla & Mistry LLP

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    Universal Capital Sec. Pvt Ltd
    21 Shakil Niwas,
    Mahakali Caves Road,Andheri (E)
    Mumbai - Mumbai - 400 093

Bliss GVS Pharma Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Bliss GVS Pharma 488.20 773.53 729.81 53.53 12.51
Abbott India 28,146.90 7,217.19 6,929.05 38.54 43.78
Astrazeneca Phar 7,905.70 2,304.07 2,275.58 116.52 27.86
P & G Health Ltd 5,953.30 944.52 934.17 27.69 71.75
Glaxosmi. Pharma 2,619.65 3,932.76 3,790.20 41.85 58.17
Novartis India 1,594.65 398.23 356.27 40.27 16.64
Cipla 1,461.55 20,102.60 18,979.95 38.41 13.88
Amrutanjan Healt 487.20 469.50 451.82 24.32 21.89
Fermenta Biotec. 473.40 474.15 450.25 21.68 18.77
Guj. Themis Bio. 352.85 152.47 150.80 78.94 27.21
Ambalal Sarabhai 44.93 19.52 3.94 31.42 6.77